Tag: radiopharmaceuticals
Clarity and Nucleus RadioPharma scale up manufacturing for cancer treatment
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has entered into a Master Services Agreement (MSA) and Clinical Manufacturing Agreement for the production of 67Cu-SAR-bisPSMA, a radiopharmaceutical treatment for prostate cancer.Â
Telix Pharmaceuticals announces manufacturing partnership with Japan’s JFE
Melbourne-based biopharmaceutical company Telix Pharmaceuticals has announced a manufacturing partnership with JFE Engineering Corporation, a Japanese company with extensive expertise in the installation of...
Australia set to become a major supplier of nuclear medicine
Australia broke ground on a new, A$168 million nuclear medicine facility, which will manufacture radiopharmaceuticals used to diagnose cancer and heart disease.
According to the...
Featured Article
Good Design Australia opens entries for 2026 awards
For more than six decades, Good Design Australia has celebrated the power of design to shape innovation, industry, and everyday life. Its flagship program, the Australian Good Design Awards, recognises projects that show how thoughtful design can enhance products, services, systems, and communities.
